Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: July 22, 2018

DrugPatentWatch Database Preview

Roxane Company Profile

« Back to Dashboard

What is the competitive landscape for ROXANE, and what generic and branded alternatives to ROXANE drugs are available?

ROXANE has one hundred and twenty-eight approved drugs.

There are fifteen tentative approvals on ROXANE drugs.

Summary for Roxane

US Patents:	0
Tradenames:	74
Ingredients:	67
NDAs:	128
Patent Litigation for Roxane:	See patent lawsuits for Roxane
PTAB Cases with Roxane as petitioner:	See PTAB cases with Roxane as petitioner

Drugs and US Patents for Roxane

+ Get email alerts for changes to this table

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Roxane	MEPROBAMATE	meprobamate	TABLET;ORAL	084332-001	Approved Prior to Jan 1, 1982		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Roxane	TERBINAFINE HYDROCHLORIDE	terbinafine hydrochloride	TABLET;ORAL	077223-001	Jul 2, 2007		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Roxane	HYDROXYUREA	hydroxyurea	CAPSULE;ORAL	074476-001	Aug 18, 1995		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Roxane	MIRTAZAPINE	mirtazapine	TABLET;ORAL	076270-001	Jun 19, 2003		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Roxane

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca

Federal Trade Commission

Cerilliant

Citi

Colorcon

Baxter

Chubb

McKesson

Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.